4D Molecular Therapeutics, Inc 10-Q for FY2023 Q2
4D Molecular Therapeutics, Inc. (FDMT)
10-Q
2023-08-09
For: 2023-06-30
View Original
Added on
April 08, 2026
About this 10-Q
4D Molecular Therapeutics, Inc filed this 10-Q on August 9, 2023, covering the quarter ended June 30, 2023 (FY2023 Q2).
Headline figures
Quarter ended June 30, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $239K
- up 47.5% from $162K a year earlier
- Net loss
- $29.62M
- compared with a net loss of $28.09M a year earlier
- Diluted EPS
- -$0.77
- compared with -$0.87 a year earlier